920 search results for “hybrid drug” in the Staff website
-
Robotic reconstitution of cytostatic drugs and monoclonal antibodies: transforming aseptic drug compounding in hospital pharmacies
PhD defence
-
Policing the Periphery: Party-anchored hybrid policing in Luanda, Angola
PhD defence
-
Leiden ‘super antibiotic’ keeps dangerous gut bacterium under control with a low dose
The antibiotic EVG7, developed in Leiden, has proven capable of fighting the dangerous gut bacterium C. difficile with only a minimal dose. What’s more, the bacterium is far less likely to return, a major issue with existing antibiotics. The research was published in Nature Communications.
-
‘Never stop trying’: Barz sees his polymers enter clinical trials
A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.
- Zomerserie Webinars Leidinggeven in Online tijden
-
Brightspace, the digital learning environment
Brightspace is the heart of the University’s digital learning environment. Lecturers can use Brightspace to support a lecture or course with digital resources. They can post assignments, lecture slides and literature in the same place and keep them up to date, giving students access to all their teaching…
-
Vici grants for research into antibodies, galaxies and Indigenous communities
Three Leiden researchers have been awarded a Vici grant by the Dutch Research Council. The funding of up to 1.5 million euros supports ‘talented, adventurous and pioneering researchers’. A total of 39 projects at Dutch institutions will receive a grant.
-
Thomas Hankemeierhankemeier@lacdr.leidenuniv.nl | 071 5274226
-
During the next pandemic, this mathematical model will speed up the search for treatment
Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer an effective treatment more quickly and efficiently. To achieve this, a team led by Coen van Hasselt is developing a platform that can speed up the process…
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
Olivier Béquignono.j.m.bequignon@lacdr.leidenuniv.nl | 071 5272727
-
Doctors discover a simple method to predict the risk of brain tumour recurrence
The risk of a brain tumour recurring can be predicted more accurately by counting the number of immune cells in the tumour under a microscope. These are the findings from research conducted by LUMC, Erasmus MC and Heidelberg University.
-
Is a cancer pill a matter of time?
A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.
-
Producing videos and podcasts
This page is helpful if you want to produce knowledge clips, ask your students to work with multimedia themselves or ‘flip’ your teaching with video or audio material.
-
CINETS 2026: Crimmigration in an Age of Authoritarian Drift
Conference
-
Daisy Batenburgd.batenburg@lacdr.leidenuniv.nl | 071 5272727
-
Kim Elbertsek.elbertse@lacdr.leidenuniv.nl | 071 5272727
-
Elsa Neuberte.neubert@lacdr.leidenuniv.nl | 071 5272727
-
Andraniek Evadgian - Weblectures and livestreams
-
Madouc Bergers made her own enzyme inhibitors for her bachelor’s thesis
For her bachelor’s thesis, Molecular Science and Technology student Madouc Bergers synthesized her own molecule that can inhibit the breakdown of sugars. Although most students do not even manage to make one building block, Madouc made three. Partly because of this, she has been nominated for the Science…
-
Myrtille Koerselmanm.e.koerselman@lacdr.leidenuniv.nl | 071 5276270
-
Kostas Tassisk.tassis@lacdr.leidenuniv.nl | 071 5276302
-
Leo Pricelsprice@lacdr.leidenuniv.nl | 071 5272727
-
Marc Boefm.a.boef@lacdr.leidenuniv.nl | 071 5272727
-
Nada Badrn.badr@lacdr.leidenuniv.nl | 071 5272727
-
Bola Khalilb.a.a.khalil@lacdr.leidenuniv.nl | 071 5272727
-
Matthijs Vlasveldm.p.vlasveld@lacdr.leidenuniv.nl | 071 5272727
-
Linde Schoenmakerl.schoenmaker@lacdr.leidenuniv.nl | 071 5274607
-
Daan Jiskootd.a.jiskoot@lacdr.leidenuniv.nl | 071 5272727
-
Chiel Jespersm.jespers@lacdr.leidenuniv.nl | 071 5272727
-
Rosan Kuinr.c.m.kuin@lacdr.leidenuniv.nl | 071 5272727
-
Nasi Liun.s.liu@lacdr.leidenuniv.nl | 071 5276225
-
Mark Fonteynem.fonteyne@lacdr.leidenuniv.nl | 071 5272727
-
Martijn Moném.j.mone@lacdr.leidenuniv.nl | 071 5276105
-
Martin Sichom.sicho@lacdr.leidenuniv.nl | 071 5274206
-
Annaloes Fokkelman-Klipj.e.fokkelman@lacdr.leidenuniv.nl | 071 5274496
-
Kirsten Veltmanc.h.j.veltman@lacdr.leidenuniv.nl | 071 5272727
-
Xiaobing Zhangx.zhang@lacdr.leidenuniv.nl | 071 5272727
-
Lukas Wijayal.s.wijaya@lacdr.leidenuniv.nl | 071 5275706
-
Sabine de Winters.de.winter@lacdr.leidenuniv.nl | 071 5272727
-
Linglu Xul.xu@lacdr.leidenuniv.nl | 071 5276039
-
Britt Duijndamb.h.a.duijndam@lacdr.leidenuniv.nl | 071 5272727
-
Lucy Sinkel.j.sinke@lacdr.leidenuniv.nl | 071 5276039
-
Mick van Schaickm.van.schaick@lacdr.leidenuniv.nl | 071 5272727
-
Gerard Mulderg.mulder@lacdr.leidenuniv.nl |
-
Arnoud Sonnenberga.sonnenberg@nki.nl | 071 5272727
-
Natasha Tahirn.tahir@lacdr.leidenuniv.nl | 071 5275919
-
Michiel van Dijkm.van.dijk@lacdr.leidenuniv.nl | 071 5274496
-
Tamara Danilyukt.y.danilyuk@lacdr.leidenuniv.nl | 071 5275919